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The rodA(Sui) mutation allows cell division to take place at 42C in fts123 mutant cells, which produce a
thermolabile penicillin-binding protein 3 (PBP3, the septation-specific peptidoglycan transpeptidase). We show
here that the mutation in rodA is a single-base change from a glutamine to a chain termination (amber) codon,
and that an amber suppressor (supE) present in the strain restores the ability to produce a reduced leyel of
normal RodA protein. The reduced level of RodA is accompanied by an increase in the levels of two other
proteins (PBP2 and PBP5) encoded by genes in the rodA operon. We show that an increased level of PBP5 is
by itself sufficient to restore cell division to fts123 cells at 420C. Two other treatments were found to restore
division capacity to the mutant: an increase in PBP6 (which is a D~alanine carboxypeptidase like PBP5) or
suitable concentrations of D-cycloserine. All of the above treatments have the effect of reducing the number of
pentapeptide side chains in peptidoglycan and increasing the number of tripeptides. We conclude that the effect
of the rodA(Sui) mutation is to indirectly increase the availability of tripeptide side chains, which are used
preferentially by PBP3 as acceptors in transpeptidation. A change in the proportions of different kinds of
peptide side chain in the peptidoglycan can therefore determine whether cells will divide.
The shape of Escherichia coli cells is determined by the
shape of the peptidoglycan layer or sacculus, which consists
of a hollow cylinder with hemispherical poles. During the
cell cycle, two morphogenetic processes alternate: cell elon-
gation, by increase in the length of the cylindrical portion of
the sacculus, and septation, with the formation of two new
hemispherical poles in the old cell center. The morphoge-
netic proteins responsible for the maintenance of the cylin-
drical shape during the elongation phase include RodA and
penicillin-binding protein 2 (PBP2), whereas a number of
proteins, including PBP3, carry out septation (7, 8, 15). The
membrane proteins PBP2 and RodA together carry out
peptidoglycan transpeptidation and transglycosylation, as
also does PBP3 (perhaps in combination with the recently
described FtsW membrane protein [10, 15]). The PBP2-
RodA and PBP3-FtsW pairs of membrane proteins therefore
carry out alternating morphogenetic modifications of the
growing sacculus and are responsible for the multiplication
of E. coli cells as rods with hemispherical poles.
In a previous paper (3) we showed that the temperature-
dependent block to division in cells with a mutation (ftsI23)
in the gene coding for PBP3 is reversed by a second mutation
[rodA(Sui)] in the gene coding for the RodA protein. In that
paper we speculated that the PBP3 and RodA proteins might
interact directly in the cell membrane, such that a mutational
change in one could be compensated for by a change in the
other. However, we have now sequenced the mutated rodA
gene and found that there is a single-base change that
converts the CAG codon of Gln-111 to a TAG amber stop
codon. Since the strain used also carries an amber suppres-
sor, supE (which recognizes UAG as a Gln codon), the only
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effect of the rodA(Sui) mutation is to produce a reduced level
of wild-type RodA protein. Therefore no conformational
change in RodA (compensating for the change in PBP3) has
in fact taken place.
In the present paper we show how the reduced level of
RodA protein can reverse the division block in mutants that
produce a temperature-sensitive PBP3. We found that the
rodA(Sui) mutation had no effect on the thermostability of
the mutant PBP3 protein but that it was accompanied by an
increase in the levels of both PBP2 and PBP5, which are also
coded for by genes in the rodA operon (16, 32). We show that
an increase in PBP5 is by itself sufficient to reverse the cell
division block in ftsI23 cells. Since PBP5 is a D-alanine
carboxypeptidase I, which catalyzes the removal of the
terminal D-alanine from pentapeptide side chains in the
peptidoglycan, an increase in this enzyme will increase the
proportion of tetrapeptide to pentapeptide side chains in the
peptidoglycan. In support of this interpretation, we find that
increased levels of PBP6, another D-alanine carboxypepti-
dase I, also reverses the division block in ftsI23 cells.
Evidence has been presented by others (2, 4, 22) that
tripeptide side chains, in which both terminal D-alanine
residues have been removed, are the favored acceptor for
transpeptidation catalyzed by PBP3. An increase in the
amount of tetrapeptide could lead to an increase in tripeptide
through the action of carboxypeptidase 11 (2). No gene for
carboxypeptidase II has yet been identified, but an increase
in the proportion of tripeptide side chains can also be
achieved by partial inhibition of the D-alanine-adding reac-
tions with the antibiotic D-cycloserine (22). In agreement
with our hypothesis, we found that appropriate levels of
D-cycloserine could also reverse the division block in fts123
cells. Finally, we show that division in suitably suppressed
ftsI23 mutant cells at 420C is, in fact, still dependent on the
residual activity of PBP3, because division is still sensitive to
specific inhibitors of PBP3.
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TABLE 1. E. coli K-12 strains, bacteriophages, and plasmids
Strain, phase, or Genotype or characteristics Source or referenceplasmid
E. coli
AB2497 thr-I leu-6 thi-J lacYl galK2 ara-14 xyl-5 mtl-i proA2 his4 argE3 rpsL31 tsx-33 Laboratory collection
supE37 thyAJ2 thyRJ4
TOE23 Like AB2497, butftsI23(Ts) 3
14 Like TOE23, but rodA(Sui) 3
KJB1 Like TOE23, but rodA(Sui), obtained by P1 transduction via 14 This study
SJC21 rodA5i(Ts) recA56 srlC300::TnlO thi-I his-4 purBI5 proA2 mtl-i xyl-5 galK2 1
lacY rpsL35
AT1325lip9 thi-i his4 purBi5 proA2 mtl-l xyl-5 galK2 lacYl lip-9 rpsL35 supE44 Laboratory collection
KEN222 Like AT1325lip9, but rodA(Sui) lip', obtained by P1 transduction via 14 3
MV1184 ara A(lac-pro) rpsL thi 480lacIZM15 A(srl-recA)306::TnJO(F' proAB lacP 34
ZM15 traD36)
Bacteriophages
P1 Laboratory collection
M13K07 Helper phage for the production of phage particles from pUC118 and pUC119 34
X clts857 11
X clts857 EamlOO9 Like X clts857, but amber mutation 1009 in gene E 11
X clts857 Eaml100 Like A cIts857, but amber mutation 1010 in gene E 11
A cIts857 Eaml102 Like A cIts857, but amber mutation 1012 in gene E 11
Plasmids
pUC13 Apr 17
pHSG398 Cmr 33
pUC118/119 Apr 34
pMA102 Apr, pBR322 carrying the pbpA and rodA genes 2
pST1 Apr, pUC13 carrying the pbpA and rodA(Sui) genes This study
pSA100 Cmr, pHSG398 carrying the rodA(Sui) gene This study
pBS47 Kmr, carrying the pbpA gene: derivative of pSC105 31
pBS59 Kmr, carrying the dacA gene: derivative of pSC105 31
pBS110 Apr, carrying the dacC gene: derivative of pSC105 6
pSU55 Apr, the 1.6-kb BamHI-EcoRI fragment carrying dacA from pBS59, under Ptac This study
control in pJF118HE
pBK18-1 Apr, 1.8-kb SmaI-EcoRI fragment carrying dacB in pUC18 W. Keck
In summary, our hypothesis is that the amber mutation in
rodA (in the presence of supE) results in a lower level of
RodA protein, which (directly or indirectly) leads to dere-
pression of the rodA operon and increased amounts of PBP5.
This increases the availability of tetrapeptide substrates for
carboxypeptidase II, which produces the tripeptide acceptor
chains used by PBP3. This increase in substrate concentra-
tion compensates for the reduced PBP3 activity at 42°C in
ftsl23 cells and allows septation to take place.
Our findings therefore support the hypothesis (4) that the
switch from cell elongation to cell divisions may be brought
about, in part, by a change in the relative availabilities of the
different peptide side chains favored by two competing
morphogenetic systems (PBP2-RodA and PBP3-FtsW). This
model for division control has been supported by the earlier
findings that the activity of carboxypeptidase II fluctuates
during the cell cycle and reaches its maximum at the time of
septation (4, 18, 19); and that increase in carboxypeptidase
Is (PBP5 and PBP6) causes cells to lose their rod shape and
become spherical (14). D-Cycloserine also causes cells to
become spherical (22). It has been proposed that the spher-
ical shape results from overactivity of the PBP3-dependent
septation system at the expense of the PBP2-RodA-depen-
dent system, which maintains the cylindrical shape of cells
during the elongation phase. Our results are fully in accord
with these interpretations.
MATERIALS AND METHODS
Bacterial strains, plasmids, and phages. The strains of E.
coli K-12, bacteriophage, and plasmids used in this work are
listed in Table 1.
Media and growth conditions. Cells were grown with
vigorous shaking in Difco L broth (LB) or Oxoid nutrient
broth no. 2 (NB); 1.5% agar was added for solid media.
Ampicillin (100 ,ug/ml), chloramphenicol (10 jig/ml), and
kanamycin (20 ,ug/ml) were added to media as required.
Molecular cloning and DNA hybridization. Cloning and
hybridization methods were based on those of Maniatis et al.
(13). Chromosomal DNA was isolated by the procedure of
Rodriguez and Tait (26). Plasmid DNA was prepared by a
modified alkaline extraction method (13). Transformation of
E. coli cells was carried out by the method of Kushner (12).
Cloning the rodA(Sui) gene. Chromosomal DNA of strain
KJB1 was digested with SmaI and BamHI and then sepa-
rated by electrophoresis on 0.8% agaros<. The pbpA and
rodA genes are found in a single 4.3-kb SmaI-BamHI frag-
ment (1), and therefore fragments of about this size were
extracted from the gel and ligated into pUC13 (17) that had
been digested with SmaI and BamHI. MV1184 (34) cells
were transformed with the plasmids. Transformants that
grew at 37°C on a nitrocellulose membrane on LB agar
containing ampicillin were replicated onto another nitrocel-
lulose membrane, which was then submitted to colony
hybridization (13). The 1.1-kb MluI-BamHI fragment con-
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taining the larger part of the rodA gene was obtained from
plasmid pMA102 (1) and used as a hybridization probe. A
DNA CHEMIPROBE kit (Takara Co., Kyoto, Japan) was
used for modification and detection of the probe (23). In this
way we obtained a plasmid, pST1, that contained the pbpA
and rodA(Sui) genes. The 1.6-kb KpnI-BamHI fragment
containing rodA(Sui) was subcloned from pST1 into the
KpnI-BamHI site of pHSG398 (33) to produce pSA100.
DNA sequencing. The restriction fragments derived from
the 1.6-kb KpnI-BamHI fragment were cloned into the
multiple cloning sites of pUC118 (34) and pUC119 (34).
Single-stranded DNA was prepared after infection with
helper phage M13K07 (34) and sequenced by the dideoxy-
chain termination method (27).
Southern hybridization. Chromosomal DNA from strains
KJB1 and TOE23 were digested with KpnI and BamHI,
separated by electrophoresis on 0.8% agarose, and stained
with ethidium bromide. DNA fragments were blotted from
the agarose gel onto a nylon membrane (Hybond-M; Amer-
sham) (24).
DNA hybridization was carried out with a 32P-labeled
oligodeoxynucleotide (13) in the presence of a competitor
oligodeoxyribonucleotide (20). The oligodeoxyribonucleo-
tides were synthesized with an Applied Biosystems model
380B DNA synthesizer.
Detection of PBPs. Cells of strains AB2497 (ftsI+), TOE23
(ftsI23), and KJB1 [ftsI23 rodA(Sui)] were grown to the
late-exponential phase in LB medium at 30°C, and crude cell
envelopes were prepared as described previously (28). The
cell envelopes were incubated at 30°C for 10 min with
[3H]penicillin (final concentration, 20 ,ug/ml, [27 Ci/mmol])
after preincubation at 42°C for 0, 1, 2.5, or 5 min. The
samples were fractionated on a 12% sodium dodecyl sulfate-
polyacrylamide gel, and the PBPs were detected by fluorog-
raphy (28).
RESULTS
Sequence of rodA(Sui). The rodA(Sui) gene was cloned into
plasmid vectors from chromosomal DNA of strain KJB1,
and its sequence was compared with that of the wild-type
rodA+ allele. Only one nucleotide difference was found: the
C at nucleotide 331 of rodA+ (16) was replaced by T in
rodA(Sui) (Fig. 1). The Sui mutation was therefore shown to
be a change from CAG (the codon for Gln-111 of the RodA
protein) to TAG (the amber termination codon).
A 32P-labeled oligonucleotide containing the mutated base
(5'-TGTTCGTTTTTAGCCGTC-3') was hybridized to chro-
mosomal DNA in the presence of an unlabeled wild-type
sequence oligonucleotide competitor. This showed that the
mutation was present in an appropriately sized KpnI-BamHI
restriction fragment of chromosomal DNA from KJB1 but
not in that from the parent strain TOE23 (data not shown).
Confirmation that strain KJB1 contains the amber suppres-
sor supE. A number of amber mutations in gene E of
bacteriophage lambda are known to be suppressed by a
suppressor mutant of glutamine-tRNA, supE, but not by
supD (serine-tRNA) or supF (tyrosine-tRNA) (11). Strain
AB2497, from which TOE23 and KJB1 were derived, carries
the amber suppressor allele supE37. To confirm that KJB1
still carried this amber suppressor, three mutant phages
carrying different supE-suppressible mutations in the E gene
(Eaml009, EamlO10, Eaml102) were used to test for the
presence of supE in KJB1. Strain KJB1 was sensitive to all
three mutant phages, as well as to the E+ parent phage. This
confirms that this strain carries supE37. The presence of the
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FIG. 1. Nucleotide sequence of the rodA(Sui) allele, in compar-
ison with that of the wild-type rodA' gene, in the region of the
mutation site. The C at nucleotide 331 in the rodA' allele (13) has
been changed to T in the rodA(Sui) allele, as indicated by arrow-
heads.
mutant glutamine-tRNA will therefore replace glutamine at
the mutated UAG codon in rodA(Sui) mRNA with low
efficiency, resulting in the production by KJB1 of a reduced
level of normal RodA protein.
Effect of rodA(Sui) on PBPs. As previously reported (3),
KIBi cells [ftsI23 rodA(Sui) supE] are able to divide at 420C,
unlike the parent T0E23 cells (fts123 supE). Figure 2 shows
the pattern of PBPs in the cell membranes of AB2497 (ftsI'
supE; the parent of T0E23), T0E23, and KJB1. The cells
were grown at 30'C; the membranes were prepared and
preincubated at 420C for 0, 1, 2.5, or 5 min before labeling
with [3H]penicillin for 10 min at 30'C (see Materials and
Methods). AB2497 and T0E23 cells showed a similar pattern
of PBPs, except that PBP3 in T0E23 was reduced in amount
even at 30'C and disappeared rapidly on incubation at 420C.
This confirmed that the fts123 mutation altered the thermo-
stability of PBP3, something that had not previously been
ftsI+ ftsl.23 ftsl.23 rodAsuli
2
3
4
5~~~~~6w1W WIWM MV
FIG. 2. PBPs in strains AB2497 (ftsI'), T0E23 (ftsI23), and
KJB1 (ftsI23 rodA(Sui]). The cells were grown to the late-exponen-
tial phase in LB at 30'C, and crude cell envelopes were prepared as
described previously (24). The cell envelopes were incubated at
30'C for 10 min with [3Hlbenzylpenicillin (final concentration, 20
~jLg/ml [27 Cilmmol]) after preincubation at 420C for 0, 1, 2.5, or 5
min. The samples were fractionated on a 12% sodium dodecyl
sulfate-polyacrylamide gel, and the PBPs were detected by fluorog-
raphy (24).
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FIG. 3. (A) Cells of strain TOE23 (ftsI23 rodA' supE) after
growth at 420C. (B) Cells of strain TOE23 carrying the plasmid
pBS59 (dacA+) after growth at 420C. The cells were grown on NB
agar plates overnight at 420C. Only cells carrying the plasmid were
able to form colonies. Bar, 10 ,um.
demonstrated directly. The presence of the rodA(Sui) muta-
tion had no detectable effect on the level or stability of PBP3;
however, this mutation was associated with a marked in-
crease in the levels of two other PBPs, PBP2 and PBP5 (Fig.
2).
To test whether cell division in KJB1 at 420C still required
the action of PBP3, the sensitivity of division to specific
inhibitors of PBP3 was tested. KJB1 and AB2497 showed
similar sensitivity to division inhibition by the PBP3-specific
inhibitors furazlocillin and mezlocillin at both 30 and 420C
(data not shown). We conclude that cell division at 420C in
KJB1 still requires the activity of PBP3.
Increased PBP5 or PBP6 enables division to take place at
420C in fts123 mutant cells. TOE23 cells were transformed
with pBS47, which carries the pbpA' gene (coding for PBP2)
together with its promoter (31). pBS47 complements pbpA
chromosomal mutations but had no effect on the temperature
sensitivity of division in TOE23. In contrast, pBS59, carry-
ing the 1.6-kb BamHI-EcoRI restriction fragment with the
dacA+ (PBP5) gene and its promoter, permitted TOE23 cells
to form colonies on plates at 42°C. Figure 3A and B show
TOE23 cells and TOE23(pBS59) cells, respectively, growing
on agar at 42°C. The presence of the plasmid has restored the
ability to divide to the PBP3 mutant cells. [TheftsI23(pBS59)
cells, although dividing, are also of increased diameter, but
ftsI+(pBS59) cells are almost spherical (18).] Another plas-
mid (pSU55) was constructed in which the 1.6-kb dacA
fragment was placed under the control of a Ptac promoter in
a high-copy-number ColEl-derived plasmid. This plasmid
allowed even better division of TOE23 cells at 420C, but the
addition of increasing concentrations of an inducer (isopro-
pyl-3-D-thiogalactopyranoside) did not further improve divi-
sion, although it did cause the cells to become increasingly
swollen. High levels of isopropyl-,3-D-thiogalactopyranoside
were lethal. Increased levels of PBP5 are therefore sufficient
to restore cell division to TOE23 mutant cells at 420C.
The dacA and pbpA genes are tightly linked to rodA, and
all three genes may be part of a single transcriptional unit
(although internal promoters are also present) (16, 30). The
increased levels of their products in rodA(Sui) cells may
therefore result from derepression of the whole operon in
response to reduced levels of RodA protein. There are other
genes in this operon (32), but they are not PBPs and were not
visible in the penicillin-labeled gels used here. The restric-
tion fragments cloned in the pBS47 and pBS59 plasmids
should not have expressed any of these other membrane
proteins; but, to demonstrate that it is increased carboxy-
peptidase I activity which restores the ability to divide to
TOE23 cells, we transformed the mutant with pBS110. This
plasmid expresses the dacC gene coding for PBP6 (5, 6),
which is also a carboxypeptidase I. Cells carrying pBS110
produce about five times the normal level of PBP6 and
become swollen to some extent. In accord with our hypoth-
esis, we found that TOE23(pBS110) cells were also able to
divide at 42°C (data not shown).
PBP4 also has D-alanine carboxypeptidase activity in
vitro, although its in vivo role is thought to be different from
that of PBP5 and PBP6. Its function may be as an endopep-
tidase (21). We found that plasmid pBK18-1, which ex-
presses the dacB gene coding for PBP4, did not restore the
ability to divide at 42°C in KJB1 cells. This supports the idea
that the role of PBP4 in vivo is different from that of PBP5
and PBP6.
We conclude that KJB1 [ftsI23 rodA(Sui) supE] cells are
able to divide at 42°C because of an increased level of the
carboxypeptidase I enzyme PBP5.
Restoration of cell division in TOE23 cells by D-cycloserine.
The D-alanine carboxypeptidase enzymes PBP5 and PBP6
cleave the terminal D-alanine from un-cross-linked pen-
tapeptide side chains in the peptidoglycan and therefore
increase the number of tetrapeptide side chains (14). These
in turn will be cleaved by D-alanine carboxypeptidase II to
produce tripeptide side chains (4). The net effect of increas-
ing either PBP5 or PBP6 might therefore be to increase the
availability of tripeptide side chains at the expense of pen-
tapeptide chains. An increased level of carboxypeptidase II
might therefore also be able to restore division to PBP3-
deficient cells. Because the gene for carboxypeptidase II has
not yet been identified, we were not able to test the effect of
increasing this enzyme. However, we were able to treat the
cells in such a way as to increase the amount of tripeptide
side chains by another route. D-Alanine dipeptide is pro-
duced from L-alanine by a racemase and a ligase and then
added to UDP-N-acetylmuramyl tripeptide to form the pen-
tapeptide precursor of mature peptidoglycan (21). The activ-
ities of the racemase and ligase can be inhibited specifically
by D-cycloserine, and cells treated with this drug have been
shown to have peptidoglycan with an increased proportion
of tripeptide side chains (22).
We therefore plated cells of AB2497 and TOE23 on plates
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FIG. 4. Schematic outline of peptidoglycan synthesis and the proposed switch between cell elongation and cell division. UDP-N-
acetylmuramyl tripeptide is converted to pentapeptide by the addition of D-alanine-D-alanine dipeptide. Subsequent reactions link these units
together, alternating with N-acetylglucosamine, in long glycan chains, which are then cross-linked by transpeptidation to form the
peptidoglycan sacculus. Pentapeptides (or possibly tetrapeptides) are always required as donors in transpeptidation reactions (21, 22). In this
scheme, synthesis of peptidoglycan in the form of a cylindrical sacculus (causing cells to grow by elongation) requires the action of PBP2,
which utilizes tetrapeptides (or possibly pentapeptides) as acceptors in transpeptidation. The formation of a septum requires transpeptidation
carried out by PBP3, which utilizes tripeptides as acceptors. The availability of tripeptides depends on both (i) the production of D-alanine-
D-alanine dipeptide and (ii) the activity of D-alanine carboxypeptidase I and II, which together remove the terminal D-alanine residues from
pentapeptide side chains. D-Cycloserine inhibits the synthesis of D-alanine-D-alanine dipeptide and causes the production of peptidoglycan
with increased numbers of tripeptide side chains (22). It is proposed that the switch from cell elongation to septation (and vice versa) depends
on changes in the availability of tripeptide acceptors brought about by periodic changes in the relative activities of carboxypeptidases (and
possibly of enzymes involved in the production of D-alanine-D-alanine dipeptide).
containing a range of concentrations of D-cycloserine and
incubated then at 30 and 420C. We found that certain
concentrations of the drug did, indeed, allow TOE23 cells to
form colonies at 420C. The most striking result was obtained
with 25 ptg/ml, which inhibited colony formation by TOE23
at 300C but permitted good colony formation at 420C, thus
reversing the normal temperature sensitivity of this strain.
DISCUSSION
We interpret our results to show that a block to cell
division caused by greatly reduced levels of the septation-
specific peptidoglycan transpeptidase PBP3 can be reversed
by an increase in the proportion of peptidoglycan with
tripeptide side chains. This is in agreement with earlier
evidence that such tripeptides are the preferred acceptor
residues in transpeptidation reactions carried out by PBP3
(4, 22). In cells with normal levels of PBP3, such an increase
in the availability of tripeptide (brought about either by
increased levels of PBP5 or PBP6 [14, 22] or by partial
inhibition by D-cycloserine of the addition of D-alanine
dipeptide [22]) results in an increase in the activity of PBP3-
dependent peptidoglycan synthesis, at the expense of that
carried out by the PBP2-RodA system, with the consequent
conversion of rod-shaped cells to coccal forms. All of the
treatments [rodA(Sui) mutation, increase in PBP5 or PBP6,
treatment with D-cycloserine] that we have found to restore
cell division to the PBP3-deficient mutant (TOE23) also
convert cells with normal levels of PBP3 into coccal forms.
These observations suggest that the cell cycle of E. coli,
consisting as it does of alternating phases of cell elongation
and septation, depends on a regularly shifting balance be-
tween the activities of two competing morphogenetic sys-
tems. We have shown that this balance can be altered by
changes in the availability of different peptide side chains.
That this may also be part of the normal regulation of the
growth and division cycle has been suggested by observa-
tions that the activities of carboxypeptidases change during
the cell cycle (4, 18, 19). Carboxypeptidase II activity has
been reported to reach a peak before cell division in normal
cells and also to show a sharp increase in activity just before
the resumption of division in cells of a division mutant that
had been returned to 30°C after a period of growth without
division at 42°C (2). Further investigation of the cycle-
dependent regulation of carboxypeptidase II may therefore
provide new insight into the way in which bacterial cells
switch from cell elongation into division.
Figure 4 shows (schematically) the way in which the two
morphogenetic systems may be connected. Glycan chains
with pentapeptide side chains are synthesized in several
steps from a UDP-N-acetylmuramyl tripeptide precursor
(21). We imagine that such pentapeptide side chains are used
preferentially in transpeptidation carried out by PBP2 and
that this somehow results in growth by elongation of the
cylindrical cell (28). D-Alanine carboxypeptidase I (PBP5
and PBP6) removes terminal D-alanine residues from pen-
tapeptides to produce tetrapeptide side chains, which are in
turn acted on by D-alanine carboxypeptidase II to produce
tripeptide side chains (21). Such tripeptides are the preferred
acceptors for transpeptidation carried out by PBP3, which is
responsible for septum formation (4). A periodic increase in
carboxypeptidase II activity (2) may perhaps be responsible
for the normal switch from cell elongation to cell division in
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growing cells, but in our experiments we achieve a similar
effect by increasing the amount of carboxypeptidase I and
thus increasing the amount of substrate (tetrapeptide side
chains) for carboxypeptidase II. In wild-type cells with
normal levels of PBP3, such an increase in substrate avail-
ability causes cells to become spherical, presumably because
the PBP2-dependent morphogenetic system is being de-
prived of substrates relative to the PBP3-dependent septum-
forming system (14); but inftsI23 mutant cells with greatly
reduced amounts of PBP3 at 420C, the increase in tripeptide
relative to pentapeptide shifts the balance of morphogenetic
activity from cell elongation into septation. The reduction in
RodA levels in cells carrying the Sui mutation indirectly
brings about this shift in substrate proportions and therefore
restores the ability to divide infts123 cells at 42TC.
Spratt (28) has estimated that normal cells contain only
about 50 molecules of PBP3. In Fig. 2 it is clear that the
number of active PBP3 molecules in TOE23 at 420C must be
very much less than this, and yet these cells, when provided
with suitable amounts of PBP3-specific substrate, are able to
carry out cell division. It will be interesting to find out how
so few molecules of PBP3 can be sufficient to carry out the
formation of a structure as large as a bacterial septum.
Pisabarro et al. (22) have shown that D-cycloserine, which
is a specific inhibitor of the L-alanine racemase and D-ala-
nine:D-alanine ligase enzymes (Fig. 4), also causes an in-
crease in the number of tripeptide side chains in the pepti-
doglycan. High levels of the drug are lethal because a
minimum number of pentapeptide (or tetrapeptide) side
chains is required for donors in transpeptidation, but at
lower concentrations the drug causes cells with normal PBP3
levels to become rounded or spherical, just like an increase
in the level of PBP5 or PBP6 (22). It is the fact that
appropriate concentrations of D-cycloserine are able to
restore division capacity toftsI23 cells at 42°C that confirms
that it is an increase in tripeptide, rather than in tetrapeptide,
that is required to restore the balance between cell elonga-
tion and septation in the mutant cells.
Our experiments show the probable way in which the Sui
mutation in the rodA gene causes the restoration of cell
division in PBP3-deficient cells. However, this does not by
itself show the way in which the switch from cell elongation
to division comes about during the normal cell cycle. The
reported cycle- and division-dependent changes in carboxy-
peptidase II activity (2) suggest that this may be part of the
mechanism of the switch, an idea which is fully supported by
our observations here. However, it is also possible that a
decrease in the activities of any or all of the three enzymes
that bring about the addition of the D-alanine dipeptide
(L-alanine racemase, D-alanine:D-alanine ligase and the
dipeptide-adding enzyme) could be part of the mechanism of
the switch. The cycle-dependent increase in carboxypepti-
dase II activity seems to depend on the prior action of the
FtsA protein (the mutation causing the temperature-sensi-
tive cell division block in the BUG6 strain used in the work
described in reference 2 has now been shown to be in the
ftsA gene [25]). Expression of PBP3 is also under negative
control by the product of the mreB gene (35) and positive
control by the ftsH gene (9). The evident complexities of the
control system governing the switch into (and out of) cell
division are now increased by our observation that the RodA
protein, required for the elongation phase of the cycle,
negatively regulates the production of PBP5, which is part of
the septation system. All of these interactions will provide a
rich field of investigation for future studies of the cell
division cycle, but for the moment it seems reasonable to
suppose that periodic shifts in the availability of peptidogly-
can with different kinds of peptide side chains may be part of
the mechanism of the cycle.
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